{
  "trial_id": "NCT01986881",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Sex, Body Mass Index (BMI), Hemoglobin A1c (A1C), Duration of Type 2 Diabetes Mellitus, Background Anti-Hyperglycemic Agents (AHA) use, History of Atherosclerosis, History of Cardiovascular Events, Smoking Status, Blood Pressure, Lipid Profile, Renal Function (e.g., eGFR), Concomitant Medications, Ethnicity, Baseline Insulin Dose (for insulin sub-study), Baseline Metformin Dose (for metformin sub-study), Baseline Sulfonylurea Dose (for sulfonylurea sub-study).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex"
        ],
        [
          "Hemoglobin A1C (A1C)",
          "Hemoglobin A1c (A1C)"
        ],
        [
          "Estimated Glomerular Filtration Rate (eGFR)",
          "Renal Function (e.g., eGFR)"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race (NIH/OMB)",
        "Fasting Plasma Glucose (FPG)",
        "Sitting Systolic Blood Pressure (SBP)",
        "Sitting Diastolic Blood Pressure (DBP)",
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "Body Mass Index (BMI)",
        "Duration of Type 2 Diabetes Mellitus",
        "Background Anti-Hyperglycemic Agents (AHA) use",
        "History of Atherosclerosis",
        "History of Cardiovascular Events",
        "Smoking Status",
        "Blood Pressure",
        "Lipid Profile",
        "Concomitant Medications",
        "Baseline Insulin Dose (for insulin sub-study)",
        "Baseline Metformin Dose (for metformin sub-study)",
        "Baseline Sulfonylurea Dose (for sulfonylurea sub-study)"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Baseline Hemoglobin A1C (A1C), Duration of Diabetes, Existing Cardiovascular Disease, Blood Pressure, Total Cholesterol, Triglycerides, Use of Anti-hyperglycemic Agents, Use of Insulin, Use of Metformin, Use of Sulfonylurea,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index"
        ],
        [
          "Hemoglobin A1C (A1C)",
          "Baseline Hemoglobin A1C (A1C)"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Fasting Plasma Glucose (FPG)",
        "Sitting Systolic Blood Pressure (SBP)",
        "Sitting Diastolic Blood Pressure (DBP)",
        "Body Weight",
        "Estimated Glomerular Filtration Rate (eGFR)"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Duration of Diabetes",
        "Existing Cardiovascular Disease",
        "Blood Pressure",
        "Total Cholesterol",
        "Triglycerides",
        "Use of Anti-hyperglycemic Agents",
        "Use of Insulin",
        "Use of Metformin",
        "Use of Sulfonylurea"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Diagnosis Duration, Existing Cardiovascular Disease, Baseline HbA1c, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, LDL Cholesterol, HDL Cholesterol, Triglycerides, eGFR, History of Myocardial Infarction, History of Stroke, History of Coronary Revascularization, History of Peripheral Artery Disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Hemoglobin A1C (A1C)",
          "Baseline HbA1c"
        ],
        [
          "Body Mass Index",
          "Body Mass Index"
        ],
        [
          "Sitting Systolic Blood Pressure (SBP)",
          "Systolic Blood Pressure"
        ],
        [
          "Sitting Diastolic Blood Pressure (DBP)",
          "Diastolic Blood Pressure"
        ],
        [
          "Estimated Glomerular Filtration Rate (eGFR)",
          "eGFR"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Fasting Plasma Glucose (FPG)",
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Diabetes Diagnosis Duration",
        "Existing Cardiovascular Disease",
        "LDL Cholesterol",
        "HDL Cholesterol",
        "Triglycerides",
        "History of Myocardial Infarction",
        "History of Stroke",
        "History of Coronary Revascularization",
        "History of Peripheral Artery Disease"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), hemoglobin A1c (A1C), type 2 diabetes mellitus duration, history of atherosclerosis, history of cardiovascular events, New York Heart Association (NYHA) heart failure class, background anti-hyperglycemic agents, smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Hemoglobin A1C (A1C)",
          "hemoglobin A1c (A1C)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Fasting Plasma Glucose (FPG)",
        "Sitting Systolic Blood Pressure (SBP)",
        "Sitting Diastolic Blood Pressure (DBP)",
        "Body Weight",
        "Estimated Glomerular Filtration Rate (eGFR)"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "type 2 diabetes mellitus duration",
        "history of atherosclerosis",
        "history of cardiovascular events",
        "New York Heart Association (NYHA) heart failure class",
        "background anti-hyperglycemic agents",
        "smoking status"
      ]
    }
  }
}